CIK 0001604464
- Non-accelerated filer
- Smaller reporting company
Atara Biotherapeutics, Inc.
Sign in to watch- Ticker
- ATRA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460920988
- Phone
- +1 805-623-4211
- Business address
- 1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
- 4 Derivatives Options or other derivatives
- 4 Open-market sale President and CEO sold 3,331 shares at $7.00 ($23,307)
- 4 Open-market sale EVP, CFO and COO sold 1,211 shares at $7.00 ($8,473)
- 4 Open-market sale EVP, Chief Regulatory Officer sold 1,059 shares at $7.00 ($7,410)
- 4 Grant or award EVP, CFO and COO acquired 34,050 shares (grant or award)
- 4 Open-market sale EVP, Chief Regulatory Officer sold 1,000 shares at $11.20 ($11,198)
- 4 Open-market sale EVP, CFO and COO sold 1,364 shares at $11.20 ($15,274)
- 4 Open-market sale President and CEO sold 1,664 shares at $11.20 ($18,633)
- 4 Grant or award President and CEO acquired 45,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale President and CEO sold 3,038 shares at an average $6.63 ($20,139)
- 4 Open-market sale EVP, Chief Sci. & Tech Officer sold 1,821 shares at an average $6.63 ($12,072)
- 4 Open-market sale EVP, Chief Legal Officer sold 1,158 shares at an average $6.63 ($7,677)
- 4 Open-market sale EVP, CFO sold 1,070 shares at an average $6.63 ($7,093)
- 4 Open-market sale EVP, Global Head RA & Quality sold 963 shares at an average $6.63 ($6,384)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale President and CEO sold 81,506 shares at $0.62 ($50,289)
- 4 Open-market sale EVP, Chief Sci. & Tech Officer sold 42,899 shares at $0.62 ($26,469)
- 4 Open-market sale EVP, Chief Legal Officer sold 32,401 shares at $0.62 ($19,991)
- 4 Open-market sale EVP, CFO sold 28,648 shares at $0.62 ($17,676)
Page 3 of 33 · 644 filings